{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:28:24Z","timestamp":1787632104523,"version":"build-2736575974"},"reference-count":180,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2006,9,1]],"date-time":"2006-09-01T00:00:00Z","timestamp":1157068800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2006,9]]},"DOI":"10.1016\/j.clindermatol.2006.07.004","type":"journal-article","created":{"date-parts":[[2006,9,11]],"date-time":"2006-09-11T11:12:21Z","timestamp":1157973141000},"page":"374-392","source":"Crossref","is-referenced-by-count":106,"title":["Systemic and localized scleroderma"],"prefix":"10.1016","volume":"24","author":[{"given":"Lorinda","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel E.","family":"Furst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fiorentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2006.07.004_bib1","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib2","series-title":"Cutaneous manifestations of rheumatic diseases","first-page":"125","article-title":"Localized cutaneous sclerosis","author":"Provost","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/path.1711660307","article-title":"Sequential dermal microvascular and perivascular changes in the development of scleroderma","volume":"166","author":"Prescott","year":"1992","journal-title":"J Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1046\/j.1365-2249.1999.00929.x","article-title":"Augmented production of chemokines (monocyte chemotactic protein\u20131 (MCP-1), macrophage inflammatory protein\u20131alpha (MIP-1alpha) and MIP-1beta) in patients with systemic sclerosis: MCP-1 and MIP-1alpha may be involved in the development of pulmonary fibrosis","volume":"117","author":"Hasegawa","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/01.dad.0000183679.40184.23","article-title":"Alterations of basement membrane zone and cutaneous microvasculature in morphea and extragenital lichen sclerosus","volume":"27","author":"Kowalewski","year":"2005","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib6","first-page":"595","article-title":"The role of vascular endothelium in the pathogenesis of connective tissue disease: endothelial injury, activation, participation and response","volume":"8","author":"Kahaleh","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11926-004-0020-5","article-title":"Systemic manifestations in localized scleroderma","volume":"6","author":"Zulian","year":"2004","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000071783","article-title":"Serum levels of tumor necrosis factor and interleukin-13 are elevated in patients with localized scleroderma","volume":"207","author":"Hasegawa","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib9","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.0906-6705.2004.00160.x","article-title":"Serum levels of manganese superoxide dismutase in patients with localized scleroderma","volume":"13","author":"Jinnin","year":"2004","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S1085-5629(98)80055-2","article-title":"The pathogenesis of cutaneous fibrosis","volume":"17","author":"Liu","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1002\/1529-0131(200103)44:3<731::AID-ANR124>3.0.CO;2-U","article-title":"Up-regulated expression of transforming growth factor beta receptors in dermal fibroblasts in skin sections from patients with localized scleroderma","volume":"44","author":"Kubo","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib12","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1085-5629(98)80059-X","article-title":"Localized scleroderma","volume":"17","author":"Tuffanelli","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1046\/j.1365-2133.2000.03407.x","article-title":"Is morphoea caused by Borrelia burgdorferi? A review","volume":"142","author":"Weide","year":"2000","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00000441-193007000-00013","article-title":"Clinical study of 103 cases of scleroderma","volume":"180","author":"O'Leary","year":"1930","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib16","first-page":"2500","article-title":"Nodular scleroderma: case report and literature review","volume":"30","author":"Cannick","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10227-002-1138-6","article-title":"Keloid morphea and nodular scleroderma: two distinct clinical variants of scleroderma?","volume":"7","author":"Rencic","year":"1999","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib18","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.jaad.2003.11.088","article-title":"Is superficial morphea synonymous with atrophoderma Pasini-Pierini?","volume":"50","author":"Jablonska","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib19","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00000372-199908000-00001","article-title":"Morphea limited to the superficial reticular dermis: an underrecognized histologic phenomenon","volume":"21","author":"McNiff","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1046\/j.1365-4362.2002.01360.x","article-title":"Bullous lesions in scleroderma","volume":"41","author":"Rencic","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib21","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"2 Pt 2","key":"10.1016\/j.clindermatol.2006.07.004_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0190-9622(98)70586-9","article-title":"Frontoparietal scleroderma (en coup de sabre) following Blaschko's lines","volume":"38","author":"Soma","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib23","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1468-3083.2002.00442.x","article-title":"Scleroderma 'en coup de sabre' and progressive facial hemiatrophy. Is it possible to differentiate them?","volume":"16","author":"Orozco-Covarrubias","year":"2002","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib24","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1525-1470.1997.tb00216.x","article-title":"Neurologic abnormalities in two patients with facial hemiatrophy and sclerosis coexisting with morphea","volume":"14","author":"Menni","year":"1997","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib25","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1212\/01.WNL.0000124518.25087.18","article-title":"Neuroimaging findings in scleroderma en coup de sabre","volume":"62","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00000372-198123000-00003","article-title":"Morphea profunda. A new concept and a histopathologic study of 23 cases","volume":"3","author":"Su","year":"1981","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib27","first-page":"70","article-title":"Diffuse fasciitis with eosinophilia: a new syndrome?","volume":"88","author":"Shulman","year":"1975","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib28","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/S0025-7125(16)30625-3","article-title":"Eosinophilic fasciitis","volume":"73","author":"Doyle","year":"1989","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib29","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1136\/ard.61.12.1111","article-title":"Eosinophilic fasciitis with multiple myeloma: a new haematological association","volume":"61","author":"Khanna","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000372-199108000-00003","article-title":"A clinical, histological, and immunohistochemical comparison of acrodermatitis chronica atrophicans and morphea","volume":"13","author":"Aberer","year":"1991","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib31","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0190-9622(87)70251-5","article-title":"Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis","volume":"17","author":"Falanga","year":"1987","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib32","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-104-6-849","article-title":"Linear scleroderma. Clinical spectrum, prognosis, and laboratory abnormalities","volume":"104","author":"Falanga","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib33","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib34","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2230.2005.01776.x","article-title":"Rheumatoid factor isotypes in localized scleroderma","volume":"30","author":"Mimura","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib35","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/art.11432","article-title":"Anti-DNA topoisomerase IIalpha autoantibodies in localized scleroderma","volume":"50","author":"Hayakawa","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib36","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1002\/1529-0131(199912)42:12<2656::AID-ANR22>3.0.CO;2-N","article-title":"Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin 1, in patients with localized scleroderma","volume":"42","author":"Arnett","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib37","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archderm.1956.01550120049012","article-title":"Localized scleroderma; a clinical study of two hundred thirty-five cases","volume":"74","author":"Christianson","year":"1956","journal-title":"A.M.A. Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib38","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","article-title":"Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma","volume":"43","author":"Hulshof","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"3 Pt 1","key":"10.1016\/j.clindermatol.2006.07.004_bib39","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0190-9622(97)80221-6","article-title":"Double-blind, placebo-controlled study of intralesional interferon gamma for the treatment of localized scleroderma","volume":"36","author":"Hunzelmann","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib40","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2133.2004.06318.x","article-title":"Localized scleroderma: response to occlusive treatment with tacrolimus ointment","volume":"152","author":"Mancuso","year":"2005","journal-title":"Br J Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.clindermatol.2006.07.004_bib41","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","volume":"39","author":"Cunningham","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib42","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2005.06776.x","article-title":"First case series on the use of imiquimod for morphoea","volume":"153","author":"Dytoc","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low-dose UVA phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1159\/000073093","article-title":"Evaluation of medium-dose UVA1 phototherapy in localized scleroderma with the cutometer and fast Fourier transform method","volume":"207","author":"de Rie","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib45","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1067\/mjd.2001.117735","article-title":"Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells","volume":"45","author":"Camacho","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib46","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1046\/j.1525-1470.2001.018003241.x","article-title":"Combined treatment with calcipotriol ointment and low-dose ultraviolet A1 phototherapy in childhood morphea","volume":"18","author":"Kreuter","year":"2001","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib47","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-0781.2004.00081.x","article-title":"Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis","volume":"20","author":"El-Mofty","year":"2004","journal-title":"PhotodermatolPhotoimmunol Photomed"},{"issue":"6 Pt 1","key":"10.1016\/j.clindermatol.2006.07.004_bib48","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(97)80277-0","article-title":"High-dose UVA1 radiation therapy for localized scleroderma","volume":"36","author":"Stege","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0781.2000.d01-1.x","article-title":"Low-dose broad-band UVA in morphea using a new method for evaluation","volume":"16","author":"El-Mofty","year":"2000","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib50","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archderm.132.11.1280","article-title":"PUVA bath photochemotherapy for localized scleroderma. Evaluation of 17 consecutive patients","volume":"132","author":"Kerscher","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib51","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.130.5.663","article-title":"Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients","volume":"130","author":"Joly","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib52","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1001\/archderm.126.5.609","article-title":"D-penicillamine in the treatment of localized scleroderma","volume":"126","author":"Falanga","year":"1990","journal-title":"Arch Dermatol"},{"issue":"2 Pt 1","key":"10.1016\/j.clindermatol.2006.07.004_bib53","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0190-9622(98)70079-9","article-title":"Low-dose methotrexate in the treatment of widespread morphea","volume":"39","author":"Seyger","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib54","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J Pediatr"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archderm.141.7.847","article-title":"Pulsed high-dose corticosteroids combined with low-dose methotrexate in severe localized scleroderma","volume":"141","author":"Kreuter","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1525-1470.1999.99016.x","article-title":"Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children","volume":"16","author":"Elst","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib57","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/978-1-4615-4857-7_44","article-title":"Treatment of generalized morphea with oral 1,25-dihydroxyvitamin D3","volume":"455","author":"Caca-Biljanovska","year":"1999","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib58","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00002281-200211000-00016","article-title":"Phototherapy for scleroderma: biologic rationale, results, and promise","volume":"14","author":"Fisher","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib59","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000246481","article-title":"Extracorporeal photochemotherapy in systemic sclerosis and severe morphea","volume":"191","author":"Cribier","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib60","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1468-3083.2003.00587.x","article-title":"Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis","volume":"17","author":"Romano","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib61","series-title":"Systemic sclerosis","author":"Clements","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib62","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/anr.1780320512","article-title":"Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study","volume":"32","author":"Furst","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib63","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","article-title":"High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib64","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/0002-9343(84)90986-0","article-title":"Factors predicting development of renal involvement in progressive systemic sclerosis","volume":"76","author":"Steen","year":"1984","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib65","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/art.1780390814","article-title":"Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype","volume":"39","author":"Arnett","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib66","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/1529-0131(200106)44:6<1359::AID-ART228>3.0.CO;2-S","article-title":"Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts","volume":"44","author":"Arnett","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib67","series-title":"Systemic sclerosis","first-page":"1","article-title":"Epidemiology, demographics and genetics","author":"Mayes","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib68","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1399-0039.1992.tb01957.x","article-title":"HLA-DPB1 alleles and autoantibody subsets in systemic lupus erythematosus, Sjogren's syndrome and progressive systemic sclerosis: a question of disease relevance","volume":"40","author":"Reveille","year":"1992","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib69","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1172\/JCI115704","article-title":"Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma)","volume":"89","author":"Reveille","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib70","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11926-001-0022-5","article-title":"Microchimerism and HLA relationships of pregnancy: implications for autoimmune diseases","volume":"3","author":"Nelson","year":"2001","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s11926-003-0044-2","article-title":"Microchimerism and scleroderma: an update","volume":"5","author":"Artlett","year":"2003","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib72","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1002\/1529-0131(200011)43:11<2598::AID-ANR30>3.0.CO;2-8","article-title":"Increased numbers of microchimeric cells of fetal origin are associated with dermal fibrosis in mice following injection of vinyl chloride","volume":"43","author":"Christner","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.bor.0000145516.45854.7b","article-title":"Microchimerism and systemic sclerosis","volume":"17","author":"Jimenez","year":"2005","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib74","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2474-2-3","article-title":"MCMV induces neointima in IFN-gammaR\u2212\/\u2212 mice: intimal cell apoptosis and persistent proliferation of myofibroblasts","volume":"2","author":"Hamamdzic","year":"2001","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib75","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0007-0963.2004.05930.x","article-title":"Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin","volume":"150","author":"Ohtsuka","year":"2004","journal-title":"Br J Dermatol"},{"issue":"Suppl 5","key":"10.1016\/j.clindermatol.2006.07.004_bib76","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1289\/ehp.99107s5793","article-title":"Occupational exposure to crystalline silica and autoimmune disease","volume":"107","author":"Parks","year":"1999","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib77","first-page":"1917","article-title":"Silica induced scleroderma\u2014clinical and experimental aspects","volume":"25","author":"Haustein","year":"1998","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib78","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/00002281-200211000-00009","article-title":"Pathogenesis of fibrosis: role of TGF-beta and CTGF","volume":"14","author":"Ihn","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib79","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1529-0131(200102)44:2<474::AID-ANR67>3.0.CO;2-#","article-title":"Blockade of endogenous transforming growth factor beta signaling prevents up-regulated collagen synthesis in scleroderma fibroblasts: association with increased expression of transforming growth factor beta receptors","volume":"44","author":"Ihn","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib80","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1165\/ajrcmb.26.2.4666","article-title":"Transforming growth factor-beta stabilizes elastin mRNA by a pathway requiring active Smads, protein kinase C-delta, and p38","volume":"26","author":"Kucich","year":"2002","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib81","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/00002281-200211000-00010","article-title":"Targeting mediators of vascular injury in scleroderma","volume":"14","author":"Schachna","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib82","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0889-857X(05)70295-7","article-title":"Systemic sclerosis. A vascular perspective","volume":"22","author":"LeRoy","year":"1996","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib83","first-page":"831","article-title":"Increased levels of endothelin-1 and differential endothelin type A and B receptor expression in scleroderma-associated fibrotic lung disease","volume":"151","author":"Abraham","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib84","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X","article-title":"Identification of elements in the promoter region of the alpha1(I) procollagen gene involved in its up-regulated expression in systemic sclerosis","volume":"41","author":"Hitraya","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib85","doi-asserted-by":"crossref","first-page":"39237","DOI":"10.1074\/jbc.M003339200","article-title":"Synergistic cooperation between Sp1 and Smad3\/Smad4 mediates transforming growth factor beta1 stimulation of alpha 2(I)\u2013collagen (COL1A2) transcription","volume":"275","author":"Zhang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib86","series-title":"Arthritis and allied conditions: a textbook of rheumatology","first-page":"1590","article-title":"Systemic sclerosis (scleroderma): clinical aspects","author":"Medsger","year":"2000"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib87","first-page":"485","article-title":"Raynaud's phenomenon: a proposal for classification","volume":"10","author":"LeRoy","year":"1992","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib88","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/art.1780400620","article-title":"The palpable tendon friction rub: an important physical examination finding in patients with systemic sclerosis","volume":"40","author":"Steen","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib89","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/art.1780210111","article-title":"Muscle disease in progressive systemic sclerosis: diagnostic and therapeutic considerations","volume":"21","author":"Clements","year":"1978","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib90","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0889-8553(05)70021-2","article-title":"Gastrointestinal manifestations of scleroderma","volume":"27","author":"Rose","year":"1998","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib91","series-title":"Systemic sclerosis","first-page":"293","article-title":"The gastrointestinal tract in systemic sclerosis","author":"Weinstein","year":"2004"},{"issue":"4 Pt 1","key":"10.1016\/j.clindermatol.2006.07.004_bib92","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/0016-5085(79)90218-X","article-title":"Progressive systemic sclerosis of the gastrointestinal tract and hereditary hollow visceral myopathy: two distinguishable disorders of intestinal smooth muscle","volume":"77","author":"Schuffler","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib93","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-113-5-352","article-title":"Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors","volume":"113","author":"Steen","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0889-857X(21)00892-9","article-title":"Epidemiology and natural history of systemic sclerosis","volume":"16","author":"Steen","year":"1990","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib95","series-title":"Systemic sclerosis","first-page":"279","article-title":"Renal involvement in systemic sclerosis","author":"Steen","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib96","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00005792-198311000-00001","article-title":"Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases","volume":"62","author":"Traub","year":"1983","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib97","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1001\/archderm.1961.01580150005001","article-title":"Systemic scleroderma, a clinical study of 727 cases","volume":"84","author":"Tuffanelli","year":"1961","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib98","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/ard.61.8.682","article-title":"Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement","volume":"61","author":"Livi","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib99","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0021-9681(73)90054-4","article-title":"Survival with scleroderma. II. A life-table analysis of clinical and demographic factors in 358 male U.S. veteran patients","volume":"26","author":"Medsger","year":"1973","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.7326\/0003-4819-75-3-369","article-title":"Survival with systemic sclerosis (scleroderma). A life-table analysis of clinical and demographic factors in 309 patients","volume":"75","author":"Medsger","year":"1971","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib101","first-page":"508","article-title":"Erectile dysfunction associated with scleroderma: a case-control study of men with scleroderma and rheumatoid arthritis","volume":"31","author":"Hong","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib102","doi-asserted-by":"crossref","first-page":"794","DOI":"10.7326\/0003-4819-104-6-794","article-title":"Impotence in scleroderma","volume":"104","author":"Nowlin","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib103","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0022-5347(01)67533-5","article-title":"Systemic sclerosis and impotence: a clinicopathological correlation","volume":"153","author":"Nehra","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib104","series-title":"Systemic sclerosis","first-page":"319","article-title":"Sexual dysfunction and pregnancy in systemic sclerosis","author":"Steen","year":"2004"},{"issue":"2 Pt 1","key":"10.1016\/j.clindermatol.2006.07.004_bib105","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0002-9378(95)90576-6","article-title":"Genital tract abnormalities and female sexual function impairment in systemic sclerosis","volume":"172","author":"Bhadauria","year":"1995","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib106","first-page":"1575","article-title":"Reproductive function prior to disease onset in women with scleroderma","volume":"19","author":"Englert","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib107","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/anr.1780320207","article-title":"Pregnancy in women with systemic sclerosis","volume":"32","author":"Steen","year":"1989","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib108","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/1529-0131(199904)42:4<763::AID-ANR21>3.0.CO;2-V","article-title":"Fertility and pregnancy outcome in women with systemic sclerosis","volume":"42","author":"Steen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0889-857X(21)00983-2","article-title":"Scleroderma","volume":"15","author":"Black","year":"1989","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib110","series-title":"Systemic sclerosis","first-page":"483","article-title":"Organ function: sexual function and pregnancy","author":"Weiner","year":"1995"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib111","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archneur.1992.00530360094024","article-title":"Neurologic manifestations of progressive systemic sclerosis","volume":"49","author":"Averbuch-Heller","year":"1992","journal-title":"Arch Neurol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib112","series-title":"Systemic sclerosis","first-page":"309","article-title":"Nervous system involvement in systemic sclerosis","author":"Herrick","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib113","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0002-9343(82)90926-3","article-title":"Trigeminal neuropathy in progressive systemic sclerosis","volume":"73","author":"Farrell","year":"1982","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib114","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1136\/ard.47.7.542","article-title":"Autonomic neuropathy in systemic sclerosis","volume":"47","author":"Klimiuk","year":"1988","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib115","series-title":"Clinical primer of rheumatology","first-page":"171","article-title":"Systemic sclerosis and Raynaud syndrome","author":"Medsger","year":"2003"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib116","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/art.1780370111","article-title":"Clinical and prognostic associations based on serum antinuclear antibodies in Japanese patients with systemic sclerosis","volume":"37","author":"Kuwana","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib117","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/art.10977","article-title":"Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis","volume":"48","author":"Hu","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib118","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.4049\/jimmunol.153.12.5838","article-title":"Association of autoantibodies to topoisomerase I and the phosphorylated (IIO) form of RNA polymerase II in Japanese scleroderma patients","volume":"153","author":"Satoh","year":"1994","journal-title":"J Immunol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib119","first-page":"639","article-title":"Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody","volume":"23","author":"Sacks","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/art.11113","article-title":"Evidence-based guidelines for the use of immunologic tests: anticentromere, Scl-70, and nucleolar antibodies","volume":"49","author":"Reveille","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib121","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/1529-0131(200002)43:2<444::AID-ANR27>3.0.CO;2-G","article-title":"Systemic sclerosis sine scleroderma: demographic, clinical, and serologic features and survival in forty-eight patients","volume":"43","author":"Poormoghim","year":"2000","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib122","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/art.1780290716","article-title":"Scleromyxedema with systemic involvement mimics rheumatic diseases","volume":"29","author":"Fudman","year":"1986","journal-title":"Arthritis Rheum"},{"issue":"5 Pt 2","key":"10.1016\/j.clindermatol.2006.07.004_bib123","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0190-9622(86)70104-7","article-title":"Scleromyxedema associated with scleroderma renal disease and acute psychosis","volume":"14","author":"Kantor","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib124","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00005792-198801000-00004","article-title":"Scleromyxedema: a scleroderma-like disorder with systemic manifestations","volume":"67","author":"Gabriel","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib125","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJM199212313272705","article-title":"Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome","volume":"327","author":"Miralles","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib126","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00005792-198007000-00006","article-title":"Plasma cell dyscrasia with polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes: the POEMS syndrome. Report on two cases and a review of the literature","volume":"59","author":"Bardwick","year":"1980","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib127","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0002-9343(94)90350-6","article-title":"POEMS syndrome: a study of 25 cases and a review of the literature. French Study Group on POEMS Syndrome","volume":"97","author":"Soubrier","year":"1994","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib128","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S1085-5629(98)80064-3","article-title":"Scleroderma-like disorders","volume":"17","author":"Jablonska","year":"1998","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib129","series-title":"Systemic sclerosis","first-page":"99","article-title":"Differential diagnosis of systemic sclerosis-like disorders","author":"Jablonska","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib130","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0190-9622(84)70146-0","article-title":"Scleredema: a review of thirty-three cases","volume":"11","author":"Venencie","year":"1984","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib131","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00000372-200308000-00017","article-title":"Nephrogenic fibrosing dermopathy: suspect identified, motive unclear","volume":"25","author":"Cowper","year":"2003","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib132","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-4632.2002.1488_3.x","article-title":"Scleromyxedema-like fibromucinosis in a patient undergoing hemodialysis","volume":"41","author":"McNeill","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1067\/mjd.2003.77","article-title":"Clinical and pathologic features of nephrogenic fibrosing dermopathy: a report of two cases","volume":"48","author":"Streams","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib134","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0002-9343(03)00085-8","article-title":"Nephrogenic fibrosing dermopathy: a novel cutaneous fibrosing disorder in patients with renal failure","volume":"114","author":"Swartz","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib135","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1097\/00002281-200311000-00017","article-title":"Nephrogenic fibrosing dermopathy: the first 6 years","volume":"15","author":"Cowper","year":"2003","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib136","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1046\/j.1525-139X.2003.16053.x","article-title":"Nephrogenic fibrosing dermopathy: an unusual skin condition associated with kidney disease","volume":"16","author":"Perazella","year":"2003","journal-title":"Semin Dial"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib137","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1002\/art.20362","article-title":"Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin","volume":"50","author":"Jimenez","year":"2004","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib138","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1365-2133.1993.tb15151.x","article-title":"Fibroblastic rheumatism: clinical, histological, immunohistological, ultrastructural and biochemical study of a case","volume":"128","author":"Lacour","year":"1993","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib139","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S0190-9622(86)80186-4","article-title":"Fibroblastic rheumatism","volume":"14","author":"Vignon-Pennamen","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib140","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/ard.2003.008441","article-title":"Fibroblastic rheumatism: a Scandinavian case report","volume":"64","author":"Pedersen","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib141","first-page":"296","article-title":"Immunohistologic and ultrastructural study of the sclerotic skin in chronic graft-versus-host disease in man","volume":"115","author":"Janin-Mercier","year":"1984","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib142","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/sj.bmt.1703386","article-title":"Progressive interstitial fibrosis of the lung in sclerodermoid chronic graft-versus-host disease","volume":"29","author":"Wolff","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib143","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1046\/j.1468-3083.2003.00606.x","article-title":"Bullous scleroderma-like changes in chronic graft-versus-host disease","volume":"17","author":"Moreno","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib144","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/art.1780220815","article-title":"A syndrome resembling progressive systemic sclerosis after bone marrow transplantation. A model for scleroderma?","volume":"22","author":"Furst","year":"1979","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib145","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0140-6736(77)90772-3","article-title":"Scleroderma-like graft-versus-host disease as late consequence of bone-marrow grafting","volume":"2","author":"Siimes","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib146","series-title":"Systemic sclerosis","first-page":"371","article-title":"Managment: holistic approach to systemic sclerosis. A Physician's approach","author":"Wigley","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib147","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-139-10-200311180-00030","article-title":"Sildenafil improved pulmonary hypertension and peripheral blood flow in a patient with scleroderma-associated lung fibrosis and the Raynaud phenomenon","volume":"139","author":"Rosenkranz","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib148","series-title":"Systemic sclerosis","first-page":"129","article-title":"Cutaneous involvement in systemic sclerosis","author":"Clements","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib149","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1056\/NEJMoa055120","article-title":"Cyclophosphamide versus placebo in scleroderma lung disease","volume":"354","author":"Tashkin","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib150","first-page":"294","article-title":"How can treatment of systemic sclerosis be improved? By setting up a national database of all cases and entering patients into trials. UK Scleroderma Study Group","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib151","series-title":"Evidence-based rheumatology","first-page":"443","article-title":"Systemic sclerosis","author":"Furst","year":"2004"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib152","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/rheumatology\/35.4.364","article-title":"Comparison of methotrexate with placebo in the treatment of systemic sclerosis: a 24 week randomized double-blind trial, followed by a 24 week observational trial","volume":"35","author":"van den Hoogen","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib153","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/1529-0131(200106)44:6<1351::AID-ART227>3.0.CO;2-I","article-title":"A randomized, controlled trial of methotrexate versus placebo in early diffuse scleroderma","volume":"44","author":"Pope","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib154","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1136\/ard.49.11.926","article-title":"5-Fluorouracil in the treatment of scleroderma: a randomised, double blind, placebo controlled international collaborative study","volume":"49","author":"Casas","year":"1990","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib155","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0889-857X(03)00026-7","article-title":"Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosis","volume":"29","author":"Lin","year":"2003","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib156","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/ard.60.6.577","article-title":"Phase I\/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease","volume":"60","author":"Binks","year":"2001","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib157","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1182\/blood.V100.5.1602.h81702001602_1602_1610","article-title":"High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes","volume":"100","author":"McSweeney","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib158","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00002281-200205000-00004","article-title":"Stem cell transplantation for autoimmune disease: progress and problems","volume":"14","author":"Furst","year":"2002","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib159","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJM199910213411703","article-title":"A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis","volume":"341","author":"Ziesche","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib160","first-page":"654","article-title":"A multicenter trial of recombinant human interferon gamma in patients with systemic sclerosis: effects on cutaneous fibrosis and interleukin 2 receptor levels","volume":"23","author":"Polisson","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib161","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/1529-0131(199902)42:2<299::AID-ANR12>3.0.CO;2-R","article-title":"Interferon-alpha does not improve outcome at one year in patients with diffuse cutaneous scleroderma: results of a randomized, double-blind, placebo-controlled trial","volume":"42","author":"Black","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib162","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/1529-0131(199906)42:6<1194::AID-ANR16>3.0.CO;2-7","article-title":"High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial","volume":"42","author":"Clements","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib163","doi-asserted-by":"crossref","first-page":"871","DOI":"10.7326\/0003-4819-132-11-200006060-00004","article-title":"Recombinant human relaxin in the treatment of scleroderma. A randomized, double-blind, placebo-controlled trial","volume":"132","author":"Seibold","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib164","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1378\/chest.120.5.1562","article-title":"Big endothelin-1 and endothelin-1 plasma levels are correlated with the severity of primary pulmonary hypertension","volume":"120","author":"Rubens","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib165","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1378\/chest.116.4.914","article-title":"Effects of long-term infusion of prostacyclin on exercise performance in patients with primary pulmonary hypertension","volume":"116","author":"Wax","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib166","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0272-5231(05)70289-6","article-title":"Medical therapy of pulmonary hypertension. The prostacyclins","volume":"22","author":"Galie","year":"2001","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib167","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1164\/ajrccm.165.6.2106079","article-title":"Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial","volume":"165","author":"Simonneau","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib168","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1164\/ajrccm.160.2.9810008","article-title":"Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis","volume":"160","author":"Olschewski","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib169","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa020204","article-title":"Inhaled iloprost for severe pulmonary hypertension","volume":"347","author":"Olschewski","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib170","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S0140-6736(01)06250-X","article-title":"Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study","volume":"358","author":"Channick","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib171","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib172","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1136\/heart.84.2.e4","article-title":"Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension","volume":"84","author":"Abrams","year":"2000","journal-title":"Heart"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib173","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1056\/NEJM200011023431814","article-title":"Sildenafil in primary pulmonary hypertension","volume":"343","author":"Prasad","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib174","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(02)11024-5","article-title":"Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial","volume":"360","author":"Ghofrani","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib175","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/hc3601.096826","article-title":"Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension","volume":"104","author":"Wilkens","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib176","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-136-7-200204020-00008","article-title":"Combination therapy with oral sildenafil and inhaled iloprost for severe pulmonary hypertension","volume":"136","author":"Ghofrani","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib177","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/00000542-200006000-00030","article-title":"Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension","volume":"92","author":"Weimann","year":"2000","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib178","first-page":"435","article-title":"Erectile dysfunction: comparison of efficacy and side effects of the PDE-5 inhibitors sildenafil, vardenafil and tadalafil\u2014review of the literature","volume":"7","author":"Gresser","year":"2002","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.clindermatol.2006.07.004_bib179","unstructured":"Sachse R, Rohde G. Tolerability and pharmacokinetics of multiple dose treatment with the new PDE5-inhibitor BAY 38-9456. in EULAR. 2000. Brussels."},{"key":"10.1016\/j.clindermatol.2006.07.004_bib180","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(98)05473-7","article-title":"Retinal side-effects of sildenafil","volume":"353","author":"Vobig","year":"1999","journal-title":"Lancet"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X06000964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X06000964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,8]],"date-time":"2023-05-08T20:24:01Z","timestamp":1683577441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X06000964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,9]]},"references-count":180,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006,9]]}},"alternative-id":["S0738081X06000964"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2006.07.004","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2006,9]]}}}